What Does FIGS (the ticker symbol) Do? — Stock Outlook, Earnings, Market Cap, Related Stocks, and Headquarters Overview
FIGS (FIGS) is a US direct-to-consumer brand company that sells premium medical apparel for healthcare professionals. Revenue and the share price are driven by its customer base, repeat purchases, and expansion into new categories and markets, making it a stock that draws significant market attention for its outlook and related names.
🏢 What kind of company is FIGS?
FIGS (FIGS) is a US direct-to-consumer brand company that sells medical apparel for healthcare professionals. It directly sells premium scrubs and medical clothing for nurses, doctors, and other healthcare workers through its own online channels, and has built its position as a differentiated brand that combines functionality with design.
Its core business is the direct sale of premium medical apparel for healthcare professionals. It directly sells functional scrubs and medical clothing, along with related products, primarily through its own online channels, expands into new categories and international markets, and operates a direct-to-consumer apparel business that grows on the back of brand loyalty and repeat purchases.
💰 How does FIGS make money?
| Business Segment | Revenue Share | Description |
|---|---|---|
| Medical Apparel | Core | Premium medical clothing such as scrubs |
| New Categories | Key Growth Driver | New categories including footwear and outerwear |
Premium medical apparel makes up the core of revenue, while expansion into new categories and international/new channels serves as the growth engine. Revenue is tied to the customer base, repeat purchases, and new customer acquisition, and the company pursues high margins through its direct-to-consumer model, although profitability can fluctuate with marketing and growth investment. Expansion of the customer base, repeat purchases, and new category and market expansion will be the key drivers of future revenue growth.
📐 FIGS market cap and company scale
Market cap is $2.2B, and the company has 388 people employees.
It is a mid-sized medical apparel brand company that leverages its specialization in healthcare-worker-focused branding, its direct-to-consumer model, and a highly loyal customer base as competitive strengths. It shares the operating environment of other apparel brands such as LEVI, COLM, and UAA, but seeks differentiation through its specialization in the medical apparel niche and its direct-to-consumer model. The company is in a stage of pursuing growth by concentrating resources on new category and international market expansion.
📈 FIGS outlook and share price trends
Expansion of the healthcare-worker customer base, repeat purchases, and new category and international market expansion are the key medium- to long-term growth drivers. A loyal base of healthcare-worker customers and the direct-to-consumer model support stable recurring revenue, while new categories and international expansion fuel growth. In the short term, softness in consumer sentiment and apparel demand, slower new customer acquisition and growth, marketing costs, and intensifying competition can act as sources of volatility for earnings and the share price.
- Expansion of the healthcare-worker customer base and repeat purchases
- Expansion into new categories such as footwear and outerwear
- International market and new channel expansion
⚔️ FIGS core strengths and risks
Specialization in healthcare-worker branding, the direct-to-consumer model, and a highly loyal customer base are strengths, while consumer sentiment, a growth slowdown, and competition are the key risks.
💪 Core Strengths
⚠️ Core Risks
🔄 FIGS competitors and related stocks (beneficiaries)
Peer companies grouped within the same apparel brand space include LEVI in denim and casual apparel, COLM in outdoor apparel, and UAA in sports apparel. Related names include LULU in premium activewear, VFC in diversified apparel brands, and GOOS in premium outerwear, and trends across these apparel brands and consumer flows connect to the operating environment of FIGS.
| Ticker | Company | Price | Change | Market Cap | P/E | PBR | ROE | Dividend Yield |
|---|---|---|---|---|---|---|---|---|
| Levi Strauss & Co | $20.12 | -1.1% | $7.7B | 16.5 | 3.4 | 25.4% | 2.97% | |
| Columbia Sportswear Co | $56.42 | +0.6% | $2.9B | 14.6 | 1.8 | 12.66% | 2.08% | |
| Under Armour Inc | $4.97 | +1.4% | $2.1B | - | 1.5 | -29.82% | - |
| Ticker | Company | Price | Change | Market Cap | P/E | PBR | ROE | Dividend Yield |
|---|---|---|---|---|---|---|---|---|
| Lululemon Athletica Inc | $96.88 | -2.9% | $11.2B | 7.9 | 2.3 | 30.9% | - | |
| VF Corp | $12.62 | -2.3% | $5.0B | 18.4 | 2.8 | 17.94% | 2.87% | |
| Canada Goose Holdings Inc | $7.63 | +0.5% | $745.1M | 19.5 | 2.0 | 11.8% | - |
✅ Checklist for FIGS investors
Key points to review when investing in FIGS. The customer base, repeat purchases, and new category and market expansion are the key short-term variables, while consumer sentiment, a growth slowdown, and marketing costs should also be monitored. | Checklist | What to Confirm | Current Status | |---|---|---| | Customer Base | Healthcare-worker customer base and repeat purchases | Expanding trend | | New Categories | Expansion into new categories such as footwear and outerwear | Growth trend | | International Expansion | International market and new channel expansion | Expanding trend | | Growth & Costs | Growth slowdown and marketing costs | Needs monitoring | Softness in consumer sentiment and apparel demand can affect revenue. Slower new customer acquisition and a growth slowdown can constrain revenue growth, and intensifying competition in medical apparel and marketing costs can also act as drivers of profitability and share-price volatility.
As a brand company that directly sells premium medical apparel for healthcare professionals, growth is expected from a highly loyal customer base, repeat purchases, and the expansion trend into new categories and international markets. However, since the stock is exposed to consumer sentiment, a growth slowdown, and competition, a dollar-cost averaging approach and a long-term perspective are recommended.